Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-ranging adjunctive ucb 34714 trial in refractory focal epilepsy
2004-001856-35Phase 2Completed
- Sponsor
- UCB
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of brivaracetam in Focal Onset Epilepsy (4 arms), sponsored by UCB. Primary endpoint: Efficacy in reducing seizure frequency. Started Dec 2004; status: completed.
02
Drugs
brivaracetam
03
Conditions
Focal Onset Epilepsy
Beyond the preview
Go deeper on 2004-001856-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001856-35.